Bioqual, Inc. engages in the provision and development of medical research and consulting services to commercial clients and government laboratories. The company is headquartered in Rockville, Maryland. The company also performs in vitro contract research services. The company is involved in the evaluation of vaccines, vaccine therapeutics, microbicides, and drug therapies. Its services also encompass sample processing and custom assays for serology, cell-mediated immunity, viral loads, and bacterial enumeration. Its additional services include advanced biocontainment (BSL3), imaging services, animal model development, and IND-enabling services. Its lab services include cell-based assays, immunoassays, toxicity and cytotoxicity testing, viral load testing, and tailored assay development.
How did BIOQ's recent EPS compare to expectations?
The most recent EPS for Bioqual Inc is $, expectations of $.
How did Bioqual Inc BIOQ's revenue perform in the last quarter?
Bioqual Inc revenue for the last quarter is $
What is the revenue estimate for Bioqual Inc?
According to of Wall street analyst, the revenue estimate of Bioqual Inc range from $ to $
What's the earning quality score for Bioqual Inc?
Bioqual Inc has a earning quality score of B+/47.026188. The score is based on a four dimension of Profitability, Growth, Cash generation & Capital Allocation, and Leverage.
When does Bioqual Inc report earnings?
Bioqual Inc next earnings report is expected in 2026-07-20
What are Bioqual Inc's expected earnings?
Bioqual Inc expected earnings is $, according to wall-street analysts.